Fulminant Myocarditis Following SARS-CoV-2 Infection: JACC Patient Care Pathways

Saurabh Rajpal; Rami Kahwash; Matthew S. Tong; Kelly Paschke; Anjali A. Satoskar; Beth Foreman; Larry A. Allen; Nicole M. Bhave; Ty J. Gluckman; Valentin Fuster

doi:10.1016/j.jaccas.2022.03.013

Fulminant Myocarditis Following SARS-CoV-2 Infection: JACC Patient Care Pathways

Saurabh Rajpal, Rami Kahwash, Matthew S. Tong, Kelly Paschke, Anjali A. Satoskar, Beth Foreman, Larry A. Allen, Nicole M. Bhave, Ty J. Gluckman, Valentin Fuster

Research output: Contribution to journal › Review article › peer-review

3 Scopus citations

Abstract

A 60-year-old woman with a past medical history of asthma presented with fulminant myocarditis 9 days after testing positive for SARS-CoV-2 and 16 days after developing symptoms consistent with COVID-19. Her hospital course was complicated by the need for veno-arterial extracorporeal membrane oxygenation, ventricular arrhythmias, and pseudomonas bacteremia. She ultimately recovered and was discharged to home with normal left ventricular systolic function. Thereafter, she developed symptomatic ventricular tachycardia, for which she received an implantable cardioverter-defibrillator and antiarrhythmic drug therapy.

Original language	English
Pages (from-to)	567-575
Number of pages	9
Journal	JACC: Case Reports
Volume	4
Issue number	10
DOIs	https://doi.org/10.1016/j.jaccas.2022.03.013
State	Published - 18 May 2022

Keywords

COVID-19
fulminant myocarditis
ventricular arrhythmias

Access to Document

10.1016/j.jaccas.2022.03.013

Cite this

@article{ceb9fe5a707e41a1ab3c2cf7fa525d5c,

title = "Fulminant Myocarditis Following SARS-CoV-2 Infection: JACC Patient Care Pathways",

abstract = "A 60-year-old woman with a past medical history of asthma presented with fulminant myocarditis 9 days after testing positive for SARS-CoV-2 and 16 days after developing symptoms consistent with COVID-19. Her hospital course was complicated by the need for veno-arterial extracorporeal membrane oxygenation, ventricular arrhythmias, and pseudomonas bacteremia. She ultimately recovered and was discharged to home with normal left ventricular systolic function. Thereafter, she developed symptomatic ventricular tachycardia, for which she received an implantable cardioverter-defibrillator and antiarrhythmic drug therapy.",

keywords = "COVID-19, fulminant myocarditis, ventricular arrhythmias",

author = "Saurabh Rajpal and Rami Kahwash and Tong, {Matthew S.} and Kelly Paschke and Satoskar, {Anjali A.} and Beth Foreman and Allen, {Larry A.} and Bhave, {Nicole M.} and Gluckman, {Ty J.} and Valentin Fuster",

note = "Publisher Copyright: {\textcopyright} 2022 American College of Cardiology Foundation",

year = "2022",

month = may,

day = "18",

doi = "10.1016/j.jaccas.2022.03.013",

language = "English",

volume = "4",

pages = "567--575",

journal = "JACC: Case Reports",

issn = "2666-0849",

publisher = "Elsevier Inc.",

number = "10",

}

TY - JOUR

T1 - Fulminant Myocarditis Following SARS-CoV-2 Infection

T2 - JACC Patient Care Pathways

AU - Rajpal, Saurabh

AU - Kahwash, Rami

AU - Tong, Matthew S.

AU - Paschke, Kelly

AU - Satoskar, Anjali A.

AU - Foreman, Beth

AU - Allen, Larry A.

AU - Bhave, Nicole M.

AU - Gluckman, Ty J.

AU - Fuster, Valentin

PY - 2022/5/18

Y1 - 2022/5/18

N2 - A 60-year-old woman with a past medical history of asthma presented with fulminant myocarditis 9 days after testing positive for SARS-CoV-2 and 16 days after developing symptoms consistent with COVID-19. Her hospital course was complicated by the need for veno-arterial extracorporeal membrane oxygenation, ventricular arrhythmias, and pseudomonas bacteremia. She ultimately recovered and was discharged to home with normal left ventricular systolic function. Thereafter, she developed symptomatic ventricular tachycardia, for which she received an implantable cardioverter-defibrillator and antiarrhythmic drug therapy.

AB - A 60-year-old woman with a past medical history of asthma presented with fulminant myocarditis 9 days after testing positive for SARS-CoV-2 and 16 days after developing symptoms consistent with COVID-19. Her hospital course was complicated by the need for veno-arterial extracorporeal membrane oxygenation, ventricular arrhythmias, and pseudomonas bacteremia. She ultimately recovered and was discharged to home with normal left ventricular systolic function. Thereafter, she developed symptomatic ventricular tachycardia, for which she received an implantable cardioverter-defibrillator and antiarrhythmic drug therapy.

KW - COVID-19

KW - fulminant myocarditis

KW - ventricular arrhythmias

UR - http://www.scopus.com/inward/record.url?scp=85129705098&partnerID=8YFLogxK

U2 - 10.1016/j.jaccas.2022.03.013

DO - 10.1016/j.jaccas.2022.03.013

M3 - Review article

C2 - 35364210

AN - SCOPUS:85129705098

SN - 2666-0849

VL - 4

SP - 567

EP - 575

JO - JACC: Case Reports

JF - JACC: Case Reports

IS - 10

ER -

Fulminant Myocarditis Following SARS-CoV-2 Infection: JACC Patient Care Pathways

Abstract

Keywords

Access to Document

Fingerprint

Cite this